Clinical Cancer Drugs

Editor-in-Chief

Giulio Francia
The University of Texas
El Paso, TX
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Complex 3D Models to Study Drug Targeting of Invadopodia

Volume:1   Issue: 2
Pp: 85-89
Njainday Pulo Jobe, Daniel Rosel, Ondrej Tolde, Jan Kosla and Jan Brabek
DOI: 10.2174/2212697X113016660003
Published on: 28 May, 2014

Preclinical Models to Study Breast Cancer open access plus

Volume:1   Issue: 2
Pp: 90-99
Cynthia M. Rodriguez, Paloma Valenzuela, Natzidielly Lerma and Giulio Francia
DOI: 10.2174/2212697X113026660005
Published on: 28 May, 2014

The Preclinical Bases of the Rational Combination of Paclitaxel and Antiangiogenic Drugs

Volume:1   Issue: 2
Pp: 100-115
Antonello Di Paolo, Guido Bocci and Romano Danesi
DOI: 10.2174/2212697X01666131218234741
Published on: 28 May, 2014

Impaired Autophagy Mediates Resistance to Low-Dose Metronomic Cyclophosphamide Chemotherapy open access plus

Volume:1   Issue: 2
Pp: 116-126
Annabelle Chow, Giulio Francia, Andrew Kouri, Christina Lee, John M. Ebos, Robert S. Kerbel and Urban Emmenegger
DOI: 10.2174/2212697X01666131218235200
Published on: 28 May, 2014

Current Overview on the Usage of Poly(ADP-ribose)polymerase (PARP) Inhibitors in Treating Cancer

Volume:1   Issue: 2
Pp: 127-148
Manikanta Swamy Murahari and Mayur C. Yergeri
DOI: 10.2174/2212697X01666140128002849
Published on: 28 May, 2014

Acknowledgements to Reviewers promotion: free to download

Volume:1   Issue: 2
Pp: 149-149

DOI: 10.2174/2212697X0102140529153231
Published on: 28 May, 2014